ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Merck, Pfizer keep high-flying vaccine sales intact with key CDC backing
July 04, 2019Looking ahead, the two companies could end up in a new head-to-head contest with their next-generation pneumococcal vaccines with billions of dollars at stake. Pfizer is developing its 20-valent follow-up to Prevnar 13, while Merck has a 15-valent vaccine
Pharma Sources Insight January 2025
